Spatial metabolomics for evaluating response to neoadjuvant therapy in non-small cell lung cancer patients.

Jian ShenNa SunPhilipp ZensThomas KunzkeAchim BuckVerena M PradeJun WangQian WangRonggui HuAnnette FeuchtingerSabina BerezowskaAxel K Walch

Published in: Cancer communications (London, England) (2022)

Our findings indicate that the metabolic constitutions of both tumor cells and the stroma are valuable additions to the classical histomorphology-based assessment of tumor response.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
lymph node
prognostic factors
rectal cancer
radiation therapy
locally advanced
bone marrow
patient reported outcomes
smoking cessation